Aviva is the UK diversified insurer providing insurance, savings, and retirement products to millions of customers. The group operates across multiple international markets and maintains commitments to net zero carbon emissions.
Ben brings venture capital and strategic investment experience from his roles at Aviva, including as founding managing director of Aviva Ventures and chairperson of Aviva Capital Partners.
Tom serves as a partner at Ventura Capital following investment roles at Aviva. He has previously held board positions at Owlstone Medical, ev.energy, and Scan.com.
Arslan brings insurance and strategy experience from roles at Aviva, Travelers, and Zurich Insurance. He also serves as a board member at Indico Data and HealthKey.
Haatch led the pre-seed round for the artificial intelligence native insurance broker to expand its engineering and data teams.
"After nearly 20 years in the industry, I’ve seen just how little has changed. Insurance is still too reliant on paperwork, underinsurance is far too common, and fees are often higher than they should be. We built Meshed to change that, to bring costs down for SMEs, give them the right protection and make the whole process faster, simpler, and more transparent."
Ventura Capital led the Series E round, with participation from Aviva Ventures, Horizons Ventures, and the Gates Foundation, to advance clinical trials and commercialise breath tests.
"Testament to the power of Breath Biopsy is the continued strong support we continue to enjoy from our investors. The funds closed will enable us to progress our business to the next stage, advancing clinical trials and supporting the launch and commercialization of our pipeline of unique breath tests."
The £6m round was led by Clean Growth Fund, Eurazeo, and Aviva Ventures to scale low-carbon heating infrastructure.
"Decarbonising heat is critical to achieving our net zero targets. Rendesco’s heat network solutions provide a cost-effective and efficient route to delivering the low-carbon heat required for the transition away from gas to renewable alternatives. This investment aligns with our commitment to empower early-stage entrepreneurs to tackle the climate change crisis."
A syndicate of 13 banks and financial institutions backed the £410m debt financing round.
"This milestone is not just a win for Zenobē but marks a significant leap forward in the movement towards a clean, low-carbon transportation sector in the UK."
Aviva Ventures led the seed financing round for the London-based healthtech firm, with participation from Ascension, Oxford Capital, and Cur8 Capital.
"So far, we’ve been driven by a singular mission to unlock and simplify access to everything you need to live a healthier life, which requires a shift in how health and well-being services are provided and paid for, and means putting the user in the driver seat and giving them more control. By creating an integrated network of health providers and payers, we can improve access to personalised health services, particularly in traditionally underfunded and underserved areas, such as early diagnosis, women’s health, mental health and neurodiversity."